Biotech - Phase 3 odds of success? What are relevant models to use?
Hi All,
I have a background in the life sciences and am new to biotech equity research.
Would love to have some advice from someone in this industry to discuss ideas around the probability of success of clinical trials. With a real emphasis on using quantitative (statistical) models to predict outcomes.
What are you guys using? How do you approach this type of analysis?
What frameworks exist for this?
Thank you!
Earum dolores doloribus recusandae. Omnis et inventore sapiente culpa fuga iusto exercitationem id.
Sed pariatur qui pariatur inventore. Unde voluptatem fugit sequi consequatur sed odit. Voluptate sit repellat eius perferendis aut ratione mollitia.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...